Mark Elliott

1.3k total citations
14 papers, 699 citations indexed

About

Mark Elliott is a scholar working on Molecular Biology, Nephrology and Oncology. According to data from OpenAlex, Mark Elliott has authored 14 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Nephrology and 3 papers in Oncology. Recurrent topics in Mark Elliott's work include Renal Diseases and Glomerulopathies (3 papers), CAR-T cell therapy research (2 papers) and Renal and related cancers (2 papers). Mark Elliott is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), CAR-T cell therapy research (2 papers) and Renal and related cancers (2 papers). Mark Elliott collaborates with scholars based in United States, Canada and Italy. Mark Elliott's co-authors include Catherine A. Hartley, Ipe Ninan, F. S. G. SOLIMAN, Charles E. Glatt, Alisa Powers, David C. Johnson, Siobhan S. Pattwell, Deqiang Jing, Stéphanie Duhoux and B.J. Casey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Journal of the American Society of Nephrology.

In The Last Decade

Mark Elliott

12 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Elliott United States	8	185	172	158	149	120	14	699
Pernilla Nikamo Sweden	16	77 0.4×	103 0.6×	255 1.6×	150 1.0×	67 0.6×	24	856
Veronica Mariotti United States	15	168 0.9×	83 0.5×	51 0.3×	24 0.2×	59 0.5×	39	669
Ashley M. Cunningham United States	13	325 1.8×	41 0.2×	86 0.5×	117 0.8×	121 1.0×	25	843
Lee Shaashua Israel	17	255 1.4×	30 0.2×	177 1.1×	123 0.8×	26 0.2×	38	958
Ryan M. Shepard United States	10	74 0.4×	74 0.4×	115 0.7×	205 1.4×	116 1.0×	15	565
Tiina Saanijoki Finland	16	88 0.5×	45 0.3×	68 0.4×	21 0.1×	35 0.3×	22	690
Tomoko Mizuno Japan	14	117 0.6×	56 0.3×	54 0.3×	28 0.2×	37 0.3×	38	682
Sandra Ackermann Switzerland	19	100 0.5×	338 2.0×	30 0.2×	70 0.5×	72 0.6×	26	1.0k
Kejin Zhang China	15	113 0.6×	83 0.5×	30 0.2×	16 0.1×	86 0.7×	63	671
Xiao-Liang Feng China	13	44 0.2×	79 0.5×	73 0.5×	43 0.3×	13 0.1×	17	480

Countries citing papers authored by Mark Elliott

Since Specialization

Citations

This map shows the geographic impact of Mark Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Elliott more than expected).

Fields of papers citing papers by Mark Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Elliott. The network helps show where Mark Elliott may publish in the future.

Co-authorship network of co-authors of Mark Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Elliott. A scholar is included among the top collaborators of Mark Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Elliott. Mark Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Elliott, Mark, et al.. (2025). Impaired Kidney Function With Kidney Tubular Vacuolization and Crystals in Adult Refsum Disease: A Case Report. Kidney Medicine. 7(11). 101107–101107.

Elliott, Mark, Margaret Helmuth, Vivette D. D’Agati, et al.. (2024). Machine Learning-Derived Predictors of Clinical Outcomes in CureGN Participants with FSGS. Journal of the American Society of Nephrology. 35(10S).

Atiquzzaman, Mohammad, Lee Er, Ognjenka Djurdjev, et al.. (2024). Implications of Implementing the 2021 CKD-EPI Equation Without Race on Managing Patients With Kidney Disease in British Columbia, Canada. Kidney International Reports. 9(4). 830–842. 3 indexed citations

Elliott, Mark, Maddalena Marasà, Enrico Cocchi, et al.. (2023). Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes. Journal of the American Society of Nephrology. 34(5). 909–919. 10 indexed citations

Elliott, Mark, Hila Milo Rasouly, & Ali G. Gharavi. (2022). Genetics of Kidney Disease: The Unexpected Role of Rare Disorders. Annual Review of Medicine. 74(1). 353–367. 8 indexed citations

Elliott, Mark, et al.. (2021). Mainstreaming Genetic Testing for Adult Patients With Autosomal Dominant Polycystic Kidney Disease. Canadian Journal of Kidney Health and Disease. 8. 1015010201–1015010201. 13 indexed citations

Elliott, Mark & Bryon Adinoff. (2021). Implications of Adult Use Cannabis Legalization for Adolescent Use, Perceptions, Health, and Consequences. Adolescent Psychiatry. 11(2). 129–146. 1 indexed citations

Clasen, Thomas, Jonathan Mellor, Karen Levy, et al.. (2020). Planning for climate change: The need for mechanistic systems-based approaches to study climate change impacts on diarrheal diseases. UNC Libraries. 1 indexed citations

Zhang, Cathy C., Zhengming Yan, Bernadette Pascual, et al.. (2017). Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia. Neoplasia. 20(1). 1–11. 16 indexed citations

10.

Chen, Shihao, Li‐Fen Lee, Timothy S. Fisher, et al.. (2014). Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model. Cancer Immunology Research. 3(2). 149–160. 207 indexed citations

11.

Jackson-Fisher, Amy, Pamela Whalen, Mark Elliott, et al.. (2014). Abstract 1958: Interrogating hedgehog pathway and smoothened inhibition by PF-04449913 in patient-derived acute myeloid leukemia models. Cancer Research. 74(19_Supplement). 1958–1958. 5 indexed citations

12.

Pattwell, Siobhan S., Stéphanie Duhoux, Catherine A. Hartley, et al.. (2012). Altered fear learning across development in both mouse and human. Proceedings of the National Academy of Sciences. 109(40). 16318–16323. 312 indexed citations

13.

Carlson, Grant W., et al.. (2001). Results of Immediate Breast Reconstruction After Skin-Sparing Mastectomy. Annals of Plastic Surgery. 46(3). 222–228. 93 indexed citations

14.

Carlson, Grant W., et al.. (2001). Breast Cancer after Augmentation Mammaplasty: Treatment by Skin-Sparing Mastectomy and Immediate Reconstruction. Plastic & Reconstructive Surgery. 107(3). 687–692. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact